434 related articles for article (PubMed ID: 25483535)
1. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
5. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
[TBL] [Abstract][Full Text] [Related]
6. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.
Crespo I; Broner S; Soldevila N; Martínez A; Godoy P; Sala-Farré MR; Company M; Rius C; Domínguez A; Group Of Catalonia TP
Hum Vaccin Immunother; 2015; 11(1):231-5. PubMed ID: 25483541
[TBL] [Abstract][Full Text] [Related]
8. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
Domínguez A; Salleras L; Carmona G; Batalla J
Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies.
Cotter SM; Sansom S; Long T; Koch E; Kellerman S; Smith F; Averhoff F; Bell BP
J Infect Dis; 2003 Apr; 187(8):1235-40. PubMed ID: 12696002
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
14. Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.
Papaevangelou V; Alexopoulou Z; Hadjichristodoulou C; Kourlamba G; Katsioulis A; Theodoridou K; Spoulou V; Theodoridou M
Hum Vaccin Immunother; 2016 Jul; 12(7):1852-6. PubMed ID: 27141813
[TBL] [Abstract][Full Text] [Related]
15. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B in Poland in 2012.
Stępień M; Piwowarow K
Przegl Epidemiol; 2014; 68(2):257-63, 363-7. PubMed ID: 25135511
[TBL] [Abstract][Full Text] [Related]
17. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
19. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
[TBL] [Abstract][Full Text] [Related]
20. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
Souto FJD; de Brito WI; Fontes CJF
Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
